Literature DB >> 12053214

Normocalcemia and persistent elevated serum concentrations of 1-84 parathyroid hormone after operation for sporadic parathyroid adenoma: evidence of increased morbidity from cardiovascular disease.

Henrik Vestergaard1, Lars ØStergaard Kristensen.   

Abstract

Elevated serum concentrations of 1-84 parathyroid hormone (PTH) after operation for sporadic parathyroid adenoma have been reported in previous studies, years after operation for primary hyperparathyroidism (pHPT). The cause and significance of this finding have not been elucidated. Primary hyperparathyroidism was diagnosed in 195 patients from January 1987 to December 1998. Operation for pHPT was performed in 124 patients. To evaluate long-term effects of elevated serum 1-84 PTH, biochemical variables and pre- and postoperative diseases were investigated from hospital case records. Of the 124 patients operated on, 103 had a solitary adenoma. Among these patients, 60 had normal serum concentrations of 1-84 PTH and calcium postoperatively, 38 patients had follow-up for more than 12 months (range 12-207 months-group A). Persistent elevated serum concentrations of 1-84 PTH and normocalcemia were found in 23 patients. Fourteen patients had follow-up for more than 12 months (range 15-76 months-group B). Two patients had persistent pHPT, and 18 were normocalcemic, but in this retrospective study data on serum 1-84 PTH were not available. No significant differences were found between groups A and B at the time of diagnosis concerning clinical characteristics. More that 12 months after operation for pHPT, the patients in group B, with persistent elevated serum concentrations of 1-84 PTH, had a significantly (c2 = 11, p = 0.005, and power of test 0.66) higher frequency of cardiovascular diseases from ischemic heart disease and hypertension. Persistent elevated serum concentrations of 1-84 PTH after operation for sporadic parathyroid adenoma may be associated with development of cardiovascular disease. This group of patients therefore needs lifelong control and, possibly, medical intervention.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12053214     DOI: 10.1007/s00268-001-0285-z

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  17 in total

1.  Longitudinal studies of mild primary hyperparathyroidism.

Authors:  S Ljunghall; S Jakobsson; C Joborn; M Palmér; J Rastad; G Akerström
Journal:  J Bone Miner Res       Date:  1991-10       Impact factor: 6.741

2.  Serum calcium: a new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years.

Authors:  L Lind; E Skarfors; L Berglund; H Lithell; S Ljunghall
Journal:  J Clin Epidemiol       Date:  1997-08       Impact factor: 6.437

3.  Inappropriate elevation of intact PTH in the presence of normocalcemia after successful surgery for primary hyperparathyroidism.

Authors:  Y Mimura; H Kanauchi; T Ogawa; F Ohkura; M Kaminishi
Journal:  Endocr J       Date:  1998-10       Impact factor: 2.349

4.  Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy.

Authors:  A Piovesan; N Molineri; F Casasso; I Emmolo; G Ugliengo; F Cesario; G Borretta
Journal:  Clin Endocrinol (Oxf)       Date:  1999-03       Impact factor: 3.478

5.  Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up.

Authors:  T Stefenelli; C Abela; H Frank; J Koller-Strametz; S Globits; J Bergler-Klein; B Niederle
Journal:  J Clin Endocrinol Metab       Date:  1997-01       Impact factor: 5.958

6.  Parathyroid hormone: before and after parathyroidectomy.

Authors:  Q Y Duh; C D Arnaud; K E Levin; O H Clark
Journal:  Surgery       Date:  1986-12       Impact factor: 3.982

7.  Parathyroid metabolism after operative treatment of hypercalcemic (primary) hyperparathyroidism.

Authors:  G L Irvin; D J Newell; S D Morgan
Journal:  Surgery       Date:  1987-12       Impact factor: 3.982

8.  Long-term effects of parathyroid operation on serum calcium and parathyroid hormone values in sporadic primary hyperparathyroidism.

Authors:  E Lundgren; J Rastad; P Ridefelt; C Juhlin; G Akerström; S Ljunghall
Journal:  Surgery       Date:  1992-12       Impact factor: 3.982

9.  Cardiac hypertrophy, hypertrophic cardiomyopathy, and hyperparathyroidism--an association.

Authors:  C Symons; F Fortune; R A Greenbaum; P Dandona
Journal:  Br Heart J       Date:  1985-11

10.  Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism.

Authors:  O Kifor; F D Moore; P Wang; M Goldstein; P Vassilev; I Kifor; S C Hebert; E M Brown
Journal:  J Clin Endocrinol Metab       Date:  1996-04       Impact factor: 5.958

View more
  10 in total

1.  Unilateral surgery for hyperparathyroidism: indications, limits, and late results--new philosophy or expensive selection without improvement of surgical results?

Authors:  Pierre-E Mortier; Marta M Mozzon; Olivier P Fouquet; Benoit C Soudan; Damien G Huglo; Jean-F Cussac; Charles A G Proye
Journal:  World J Surg       Date:  2004-11-11       Impact factor: 3.352

Review 2.  Elevated parathyroid hormone levels after successful parathyroidectomy for primary hyperparathyroidism: a clinical review.

Authors:  Roberto de la Plaza Llamas; José Manuel Ramia Ángel; Vladimir Arteaga Peralta; Cristina García Amador; Aylhín Joana López Marcano; Aníbal Armando Medina Velasco; Begoña González Sierra; Alba Manuel Vázquez; Raquel Aránzazu Latorre Fragua
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-12-05       Impact factor: 2.503

3.  Myocardial perfusion defects and the left ventricular ejection fraction disclosed by scintigraphy in patients with primary hyperparathyroidism.

Authors:  Christina Gerlach Ogard; Susanne Bonnichsen Søndergaard; Henrik Vestergaard; Henrik Jakobsen; Steen Levin Nielsen
Journal:  World J Surg       Date:  2005-07       Impact factor: 3.352

4.  Original Research: Atorvastatin prevents rat cardiomyocyte hypertrophy induced by parathyroid hormone 1-34 associated with the Ras-ERK signaling.

Authors:  Xiaogang Liu; Chunbo Zou; Chengyuan Yu; Rujuan Xie; Manshu Sui; Suhong Mu; Li Li; Shilei Zhao
Journal:  Exp Biol Med (Maywood)       Date:  2016-05-10

5.  Endothelial function and endothelial nitric oxide synthase intron 4a/b polymorphism in primary hyperparathyroidism.

Authors:  A Ekmekci; N Abaci; N Colak Ozbey; A Agayev; N Aksakal; H Oflaz; N Erginel-Unaltuna; Y Erbil
Journal:  J Endocrinol Invest       Date:  2009-07-02       Impact factor: 4.256

6.  Serum ionised calcium and cardiovascular disease in 45-years old men and women followed for 18 years.

Authors:  Christina Gerlach Ogard; Janne Petersen; Torben Jørgensen; Thomas Almdal; Henrik Vestergaard
Journal:  Eur J Epidemiol       Date:  2006       Impact factor: 8.082

Review 7.  Parathyroid hormone and the cardiovascular system.

Authors:  Lorraine A Fitzpatrick; John P Bilezikian; Shonni J Silverberg
Journal:  Curr Osteoporos Rep       Date:  2008-06       Impact factor: 5.096

8.  [Primary hyperparathyroidism. Postoperative normocalcemic hyperparathyrinemia after curative parathyroidectomy].

Authors:  M Hermann
Journal:  Chirurg       Date:  2010-05       Impact factor: 0.955

9.  Oxidative stress and angiogenesis in primary hyperparathyroidism.

Authors:  Mariusz Deska; Ewa Romuk; Oliwia Anna Segiet; Grzegorz Buła; Witold Truchanowski; Dominika Stolecka; Ewa Birkner; Jacek Gawrychowski
Journal:  Eur Surg       Date:  2016-12-14       Impact factor: 0.953

10.  The association between parathyroid hormone and mortality in dialysis patients is modified by wasting.

Authors:  Christiane Drechsler; Vera Krane; Diana C Grootendorst; Eberhard Ritz; Karl Winkler; Winfried März; Friedo Dekker; Christoph Wanner
Journal:  Nephrol Dial Transplant       Date:  2009-05-27       Impact factor: 5.992

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.